Novo Nordisk Recalls Insulin Pens All Over Europe

Law360, New York (October 25, 2013, 3:26 PM EDT) -- Novo Nordisk A/S said Friday it's recalling certain batches of NovoMix 30 FlexPen, a prefilled insulin product, in Europe because they don't meet the specifications for insulin strength, which could lead to the patient’s blood sugar level becoming higher or lower than expected.

The company is recalling some NovoMix 30 FlexPens in Austria, Belgium, the Czech Republic, Denmark, France, Germany, Iceland, Luxemburg, the Netherlands, Norway and Slovakia. In Ireland and the U.K., three batches of NovoMix 30 Penfill are being recalled. The company said other countries...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.